The Dana-Farber Cancer Institute at the Brigham and Women’s Hospital in Boston, MA is looking for Mesothelioma patients to take part in a clinical trial that will study the results of a combination of chemotherapy (consisting of gemcitabine and cisplatin) administered in the operating room as well as put into the chest and abdomen for one hour.

The study also hopes to determine the effects of heating the chemotherapy to 42 degrees Celsius and how cytoprotection agents amifostine and sodium thiosulfate counteract potential side effects of the chemotherapy. In addition to the chemotherapy there will be surgery including resection of the lung and lung lining, the covering of the heart and the muscle between the chest and the abdomen.

The Mesothelioma study is planned to be completed in 2010.

If you are interested in the clinical trial you can contact the hospital to see if you are eligible.